Cargando…
Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
[Image: see text] The success of vaccination with subunit vaccines often relies on the careful choice of adjuvants. There is great interest in developing new adjuvants that can elicit a cellular immune response. Here, we address this challenge by taking advantage of the synergistic cross-talk betwee...
Autores principales: | Guzelj, Samo, Weiss, Matjaž, Slütter, Bram, Frkanec, Ruža, Jakopin, Žiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706565/ https://www.ncbi.nlm.nih.gov/pubmed/36335509 http://dx.doi.org/10.1021/acs.jmedchem.2c00808 |
Ejemplares similares
-
Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022) -
Structural Fine-Tuning
of Desmuramylpeptide NOD2 Agonists
Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021) -
Discovery
of Desmuramylpeptide NOD2 Agonists with
Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022) -
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
por: Guzelj, Samo, et al.
Publicado: (2022) -
Synthesis of Conformationally Constrained d-Glu-meso-DAP Analogs as Innate Immune Agonists
por: Guzelj, Samo, et al.
Publicado: (2020)